Diabetes Care, Vol 18, Issue 3 292-299, Copyright © 1995 by American Diabetes Association

ARTICLES

Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Importance of visceral adipose tissue

A Tchernof, JP Despres, A Dupont, A Belanger, A Nadeau, D Prud'homme, S Moorjani, PJ Lupien and F Labrie
Lipid Research Center, CHUL Research Center, Ste-Foy, Quebec, Canada.

OBJECTIVE--Low plasma testosterone levels are associated with hyperinsulinemia and glucose intolerance in men. However, it is unclear whether these abnormalities are related to the concomitant alteration in regional adipose tissue (AT) accumulation associated with reduced androgen levels. RESEARCH DESIGN AND METHODS--We measured plasma steroid levels in a sample of 79 men, ranging from lean to obese (aged 29-42 years), for whom an oral glucose tolerance test (OGTT), anthropometric and computed tomography (CT) measurements of body fatness, and AT distribution were performed. Sex hormone binding globulin (SHBG) and the following steroids were measured after extraction from plasma and chromatography: dehydroepiandrosterone, androstenedione, androst-5-ene-3 beta,17 beta-diol, testosterone, estrone, and estradiol (E2). RESULTS--Several significant negative correlations were found between adrenal C19 steroid precursors, testosterone, SHBG, and fasting insulin levels, as well as between plasma glucose and insulin concentrations measured during the OGTT (-0.25 < or = r < or = -0.35, 0.05 > or = P > or = 0.001). The best steroid correlate of plasma glucose and insulin homeostasis indexes was the E2: testosterone ratio (0.34 < or = r < or = 0.42, 0.005 > or = P > or = 0.001). However, after correction of steroid levels for either fat mass, body mass index (BMI), or visceral AT area, as measured by CT, no significant residual associations were noted between testosterone, adrenal C19 steroid, SHBG, and estrogen levels and indexes of plasma glucose-insulin homeostasis, although the positive association between the E2: testosterone ratio and glucose area remained significant after adjustment for total body fat mass and BMI. Furthermore, 15 pairs of obese subjects, matched for visceral AT area, showing either low or high levels of the steroids studied, did not differ in fasting insulin and postglucose plasma insulin levels or in glucose tolerance. CONCLUSIONS--These results suggest that the previously reported relationships between androgen levels and indexes of plasma glucose-insulin homeostasis are mediated, to a large extent, by concomitant alterations in levels of total body fat and visceral AT in men.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. T. Campbell, M. Cotterchio, E. Dicks, P. Parfrey, S. Gallinger, and J. R. McLaughlin Excess Body Weight and Colorectal Cancer Risk in Canada: Associations in Subgroups of Clinically Defined Familial Risk of Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1735 - 1744. [Abstract] [Full Text] [PDF]

				F Labrie Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA. Endocr. Relat. Cancer, June 1, 2006; 13(2): 335 - 355. [Abstract] [Full Text] [PDF]

				D. J. Clegg, L. M. Brown, S. C. Woods, and S. C. Benoit Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes, April 1, 2006; 55(4): 978 - 987. [Abstract] [Full Text] [PDF]

				E E Frezza, M S Wachtel, and M Chiriva-Internati Influence of obesity on the risk of developing colon cancer Gut, February 1, 2006; 55(2): 285 - 291. [Full Text] [PDF]

				G. B. Phillips Is Atherosclerotic Cardiovascular Disease an Endocrinological Disorder? The Estrogen-Androgen Paradox J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2708 - 2711. [Abstract] [Full Text] [PDF]

				E. C. Tsai, A. M. Matsumoto, W. Y. Fujimoto, and E. J. Boyko Association of Bioavailable, Free, and Total Testosterone With Insulin Resistance: Influence of sex hormone-binding globulin and body fat Diabetes Care, April 1, 2004; 27(4): 861 - 868. [Abstract] [Full Text] [PDF]

				N. Abate, S. M. Haffner, A. Garg, R. M. Peshock, and S. M. Grundy Sex Steroid Hormones, Upper Body Obesity, and Insulin Resistance J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4522 - 4527. [Abstract] [Full Text] [PDF]

				J.-Y. Oh, E. Barrett-Connor, N. M. Wedick, and D. L. Wingard Endogenous Sex Hormones and the Development of Type 2 Diabetes in Older Men and Women: the Rancho Bernardo Study Diabetes Care, January 1, 2002; 25(1): 55 - 60. [Abstract] [Full Text] [PDF]

				T. K. Murphy, E. E. Calle, C. Rodriguez, H. S. Kahn, and M. J. Thun Body Mass Index and Colon Cancer Mortality in a Large Prospective Study Am. J. Epidemiol., November 1, 2000; 152(9): 847 - 854. [Abstract] [Full Text] [PDF]

				J. Pritchard, J.-P. Després, J. Gagnon, A. Tchernof, A. Nadeau, A. Tremblay, and C. Bouchard Plasma Adrenal, Gonadal, and Conjugated Steroids before and after Long Term Overfeeding in Identical Twins J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3277 - 3284. [Abstract] [Full Text]

				A. Tchernof, F. Labrie, A. Belanger, D. Prud'homme, C. Bouchard, A. Tremblay, A. Nadeau, and J.-P. Despres Androstane-3{alpha},17{beta}-Diol Glucuronide as a Steroid Correlate of Visceral Obesity in Men J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1528 - 1534. [Abstract] [Full Text] [PDF]